NCT01272037 2026-04-13
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
18 trialsNCT01349322 2026-03-05
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Radiation Therapy Oncology Group
Phase 3 Active not recruiting
NCT00757302 2025-12-22
Intraoperative Gamma Camera for Breast Cancer Surgery
University Hospital, Strasbourg, France
Phase 3 Completed
NCT00769379 2025-06-12
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
National Cancer Institute (NCI)
Phase 3 Completed
NCT01905046 2025-04-13
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
NCT00072462 2024-09-19
IBIS-II DCIS
Queen Mary University of London
Phase 3 Completed
NCT04722692 2023-08-03
SENTINOT_2
Uppsala University
Phase 3 Recruiting
NCT01357772 2023-07-17
TAM-01
Ente Ospedaliero Ospedali Galliera
Phase 3 Active not recruiting
NCT00003857 2022-05-25
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
Radiation Therapy Oncology Group
Phase 3 Completed
NCT02961790 2020-01-18
Oxybutynin Chloride in Managing Hot Flashes
Academic and Community Cancer Research United
Phase 3 Completed
NCT04046159 2019-08-06
Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ
National Taiwan University Hospital
Phase 3 Unknown
NCT00053898 2018-09-20
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
NSABP Foundation Inc
Phase 3 Completed
NCT00438659 2016-08-01
Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT01112254 2016-01-26
IRCIS
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Completed
NCT01185132 2014-06-26
2009-APBI
Rocky Mountain Cancer Centers
Phase 3 Recruiting
NCT00262899 2013-01-07
Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions
Georgetown University
Phase 3 Completed
NCT00324714 2012-11-29
Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS
ETOP IBCSG Partners Foundation
Phase 3 Withdrawn
NCT00002920 2012-10-31
S9630, Medroxyprogesterone in Treating Women With Breast Cancer
SWOG Cancer Research Network
Phase 3 Completed